Racial Differences in Clinical Features and Comorbidities in Ankylosing Spondylitis in the United States

REFERENCES

1. 1.↵
   1. Jamalyaria F,
   2. Ward MM,
   3. Assassi S,
   4. Learch TJ,
   5. Lee M,
   6. Gensler LS,
   7. et al.

   Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol 2017;36:2359–64.

   OpenUrl
2. 2.↵
   1. Khan MA,
   2. Kushner I,
   3. Braun WE

   . Low incidence of HLA-B27 in American Blacks with spondyloarthropathies. Lancet 1976;1:483.

   OpenUrlPubMed
3. 3.↵
   1. Khan MA,
   2. Kushner I,
   3. Braun WE

   . Comparison of clinical features in HLA-B27 positive and negative patients with AS. Arthritis Rheum 1997;20:909–12.

   OpenUrl
4. 4.↵
   1. Baum J,
   2. Ziff M

   . The rarity of ankylosing spondylitis in the black race. Arthritis Rheum 1971;14:12–8.

   OpenUrlPubMed
5. 5.↵
   1. Mijiyawa M,
   2. Oniankitan O,
   3. Khan MA

   . Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281–6.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Reveille JD,
   2. Witter JP,
   3. Weisman MH

   . Prevalence of axial spondyloarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res 2012;64:905–10.

   OpenUrlCrossRef
7. 7.↵
   1. SNOMED International

   . [Internet. Accessed December 23, 2019.] Available from: www.snomed.org
8. 8.↵
   1. Nelson SJ,
   2. Zeng K,
   3. Kilbourne J,
   4. Powell T,
   5. Moore R

   . Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc 2011;18:441–8.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. McDonald CJ,
   2. Huff SM,
   3. Suico JG,
   4. Hill G,
   5. Leavelle D,
   6. Aller R,
   7. et al.

   LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem 2003;49:624–33.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Belachew DA,
    2. Sandu N,
    3. Schaller B,
    4. Guta Z

    . Ankylosing spondylitis in sub-Saharan Africa. Postgrad Med J 2009;85:353–7.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Tikly M,
    2. Njobvu P,
    3. McGill P

    . Spondyloarthritis in sub-Saharan Africa. Curr Rheumatol Rep 2014;16:421.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Chalmers IM

    . Ankylosing spondylitis in African blacks. Arthritis Rheum 1980;23:1366–70.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Robinson PC,
    2. Leo PJ,
    3. Pointon JJ,
    4. Harris J,
    5. Cremin K,
    6. Bradbury LA,
    7. et al;
    8. Australasian Osteoporosis Genetics Consortium AOGC

    . The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis. Genes Immun 2016;17:46–51.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Benegas M,
    2. Muñoz-Gomariz E,
    3. Font P,
    4. Burgos-Vargas R,
    5. Chaves J,
    6. Palleiro D,
    7. et al;
    8. RESPONDIA group;
    9. ASPECT study group;
    10. REGISPONSER study group

    . Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol 2012;39:2315–20.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Putrik P,
    2. Ramiro S,
    3. Moltó A,
    4. Keszei A,
    5. Norton S,
    6. Dougados M,
    7. et al.

    Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA). Ann Rheum Dis 2019;78:486–93.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Nikiphorou E,
    2. van der Heijde D,
    3. Norton S,
    4. Landewé R,
    5. Molto A,
    6. Dougados M,
    7. et al.

    Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study. Ann Rheum Dis 2018;77:405–11.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Patel VN,
    2. Kaelber DC

    . Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine. J Biomed Inform 2014;52:36–42.

    OpenUrl
18. 18.↵
    1. Kaelber DC,
    2. Foster W,
    3. Gilder J,
    4. Love TE,
    5. Jain AK

    . Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc 2012;19:965–72.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Glover M,
    2. Mansoor E,
    3. Panhwar M,
    4. Parasa S,
    5. Copper GS

    . Epidemiology of colorectal cancer in average risk adults 20–39 years of age: a population-based national study. Dig Dis Sci 2019;64:3602–9.

    OpenUrl
20. 20.↵
    1. Wu JJ,
    2. Lu M,
    3. Veverka KA,
    4. Smulders M,
    5. Papademetriou E,
    6. Yu J,
    7. et al.

    The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment. J Dermatolog Treat 2019;30:446–53.

    OpenUrl